Literature DB >> 568219

A study of the sites of interaction between dopamine and 5-hydroxytryptamine for the production of fluphenazine-induced catalepsy.

C J Carter, C J Pycock.   

Abstract

The effect of reducing 5-hydroxytryptamine (5-HT) concentration within various areas of the central dopamine (DA) system on catalepsy has been investigated. The neurotoxin 5,7-dihydroxytryptamine was used to selectively deplete 5-HT in the striatum, nucleus accumbens septi, tuberculum olfactorium or substantia nigra. Localised depletion of 5-HT within the nucleus accumbens septi and substantia nigra reduced the cataleptic effects of the neuroleptic agent fluphenazine, while lesions of the striatum or tuberculum olfactorium were without effect. Each injection of neurotoxin resulted in a 38--47% depletion of 5-HT in the target site: DA levels were not significantly altered. The results suggest that varied dopamine/5-hydroxytryptamine interactions within the nucleus accumbens may contribute to the action of the neuroleptic. The reduction of fluphenazine-induced catalepsy produced by 5-HT depletion within the substantia nigra supports the concept of a controlling influence of 5-HT on nigro-striatal DA function.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 568219     DOI: 10.1007/bf00495549

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  25 in total

1.  Antagonistic effect of cyproheptadine on neuroleptic-induced catalepsy.

Authors:  J Maj; E Mogilnicka; B Przewlocka
Journal:  Pharmacol Biochem Behav       Date:  1975 Jan-Feb       Impact factor: 3.533

2.  Reduced cataleptogenic effects of some neuroleptics in rats with lesioned midbrain raphe and treated with p-chlorophenylalanine.

Authors:  W Kostowski; W Gumulka; A Cxlonkowski
Journal:  Brain Res       Date:  1972-12-24       Impact factor: 3.252

3.  Serotonergic inhibition of catecholamine-induced behavioral arousal.

Authors:  P D Mabry; B A Campbell
Journal:  Brain Res       Date:  1973-01-30       Impact factor: 3.252

4.  Effect of intraventricular injection of 5,7-dihydroxytryptamine on regional tryptophan hydroxylase of rat brain.

Authors:  H G Baumgarten; S J Victor; W Lovenberg
Journal:  J Neurochem       Date:  1973-07       Impact factor: 5.372

5.  5,7-Dihydroxytryptamine as a tool for the morphological and functional analysis of central 5-hydroxytryptamine neurons.

Authors:  J Daly; K Fuxe; G Jonsson
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1974-01

6.  Modification of the behavioural changes induced by haloperidol in the ray by lesions in the caudate nucleus, the caudate-putamen and globus pallidus.

Authors:  R J Naylor; J E Olley
Journal:  Neuropharmacology       Date:  1972-01       Impact factor: 5.250

7.  Possible importance of 5-hydroxytryptamine in neuroleptic-induced catalepsy in rats [proceedings].

Authors:  C J Carter; C J Pycock
Journal:  Br J Pharmacol       Date:  1977-06       Impact factor: 8.739

Review 8.  Effects of drugs on the processes regulating the functional activity of brain 5-hydroxytryptamine.

Authors:  A R Green; D G Grahame-Smith
Journal:  Nature       Date:  1976-04-08       Impact factor: 49.962

9.  Regional changes in cerebral GABA concentration and convulsions produced by D and by L-allylglycine.

Authors:  R W Horton; A G Chapman; B S Meldrum
Journal:  J Neurochem       Date:  1978-06       Impact factor: 5.372

10.  Antagonism of the hyperactivity induced by dopamine applied intracerebrally to the nucleus accumbens septi by typical neuroleptics and by clozapine, sulpiride and thioridazine.

Authors:  B Costall; R J Naylor
Journal:  Eur J Pharmacol       Date:  1976-01       Impact factor: 4.432

View more
  9 in total

1.  5-Hydroxytryptamine acts at 5-HT2 receptors to decrease potassium conductance in rat nucleus accumbens neurones.

Authors:  R A North; N Uchimura
Journal:  J Physiol       Date:  1989-10       Impact factor: 5.182

2.  Metoclopramide antagonism of 5-hydroxytryptophan-induced "wet-dog" shake behaviour in the rat.

Authors:  J R Fozard; M G Palfreyman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-06       Impact factor: 3.000

3.  The Yawning elicited by alpha-melanocyte-stimulating hormone involves serotonergic-dopaminergic-cholinergic neuron link in rats.

Authors:  K Yamada; T Furukawa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-04       Impact factor: 3.000

4.  Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressant.

Authors:  H Y Meltzer; M Young; J Metz; V S Fang; P M Schyve; R C Arora
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

5.  The effects of 5,7-dihydroxytryptamine lesions of extrapyramidal and mesolimbic sites on spontaneous motor behaviour, and amphetamine-induced stereotypy.

Authors:  C J Carter; C J Pycock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-07       Impact factor: 3.000

6.  The influence of cerebral 5-hydroxytryptamine on catalepsy induced by brain-amine depleting neuroleptics or by cholinomimetics.

Authors:  L D Fuenmayor; M Vogt
Journal:  Br J Pharmacol       Date:  1979-10       Impact factor: 8.739

Review 7.  Noradrenaline and 5-hydroxytryptamine modulation of brain dopamine function: implications for the treatment of Parkinson's disease.

Authors:  P Jenner; M Sheehy; C D Marsden
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

8.  Effects of gepirone, an aryl-piperazine anxiolytic drug, on aggressive behavior and brain monoaminergic neurotransmission.

Authors:  B A McMillen; S M Scott; H L Williams; M K Sanghera
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-04       Impact factor: 3.000

9.  Effect of metergoline, fenfluramine, and 8-OHDPAT on catalepsy induced by haloperidol or morphine.

Authors:  C L Broekkamp; S K Oosterloo; H H Berendsen; A M van Delft
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-08       Impact factor: 3.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.